Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity

v3.25.2
Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2023   75,131,425      
Beginning Balance at Dec. 31, 2023 $ 234,300 $ 7 $ 390,083 $ 3,964 $ (159,754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   631,463      
Issuance of common stock upon exercise of stock options 113   113    
Issuance of common stock upon settlement of restricted stock units (in shares)   1,586,632      
Stock-based compensation - restricted stock 9,965   9,965    
Shares withheld related to net share settlement (in shares)   (344,331)      
Shares withheld related to net share settlement (1,023)   (1,023)    
Issuance of common stock for settlement of contingent consideration compensation (earn-out) (in shares)   1,008,998      
Issuance of common stock for settlement of contingent consideration compensation (earn-out) 3,022   3,022    
Repurchase and retirement of common stock (in shares)   (80,102)      
Repurchase and retirement of common stock (244)   (407)   163
Other comprehensive income (loss) (1,187)     (1,187)  
Net loss (15,560)       (15,560)
Ending Balance (in shares) at Jun. 30, 2024   77,934,085      
Ending Balance at Jun. 30, 2024 229,386 $ 7 401,753 2,777 (175,151)
Beginning Balance (in shares) at Dec. 31, 2023   75,131,425      
Beginning Balance at Dec. 31, 2023 234,300 $ 7 390,083 3,964 (159,754)
Ending Balance (in shares) at Dec. 31, 2024   79,419,028      
Ending Balance at Dec. 31, 2024 221,938 $ 7 407,076 1,753 (186,898)
Beginning Balance (in shares) at Mar. 31, 2024   77,146,050      
Beginning Balance at Mar. 31, 2024 236,609 $ 7 397,477 3,113 (163,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   123,282      
Issuance of common stock upon exercise of stock options 22   22    
Issuance of common stock upon settlement of restricted stock units (in shares)   1,077,067      
Stock-based compensation - restricted stock 5,647   5,647    
Shares withheld related to net share settlement (in shares)   (332,212)      
Shares withheld related to net share settlement (986)   (986)    
Repurchase and retirement of common stock (in shares)   (80,102)      
Repurchase and retirement of common stock (244)   (407)   163
Other comprehensive income (loss) (336)     (336)  
Net loss (11,326)       (11,326)
Ending Balance (in shares) at Jun. 30, 2024   77,934,085      
Ending Balance at Jun. 30, 2024 229,386 $ 7 401,753 2,777 (175,151)
Beginning Balance (in shares) at Dec. 31, 2024   79,419,028      
Beginning Balance at Dec. 31, 2024 221,938 $ 7 407,076 1,753 (186,898)
Ending Balance (in shares) at Mar. 31, 2025   80,973,634      
Ending Balance at Mar. 31, 2025 219,732 $ 7 407,047 3,069 (190,391)
Beginning Balance (in shares) at Dec. 31, 2024   79,419,028      
Beginning Balance at Dec. 31, 2024 $ 221,938 $ 7 407,076 1,753 (186,898)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,611,847 1,611,847      
Issuance of common stock upon exercise of stock options $ 74   74    
Issuance of common stock upon settlement of restricted stock units (in shares)   2,450,677      
Stock-based compensation - restricted stock 9,566   9,566    
Shares withheld related to net share settlement (in shares)   (1,785,947)      
Shares withheld related to net share settlement (5,457)   (5,457)    
Other comprehensive income (loss) 4,215     4,215  
Net loss (7,236)       (7,236)
Ending Balance (in shares) at Jun. 30, 2025   81,695,605      
Ending Balance at Jun. 30, 2025 223,100 $ 7 411,259 5,968 (194,134)
Beginning Balance (in shares) at Mar. 31, 2025   80,973,634      
Beginning Balance at Mar. 31, 2025 219,732 $ 7 407,047 3,069 (190,391)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   43,680      
Issuance of common stock upon exercise of stock options 14   14    
Issuance of common stock upon settlement of restricted stock units (in shares)   985,270      
Stock-based compensation - restricted stock 5,349   5,349    
Shares withheld related to net share settlement (in shares)   (306,979)      
Shares withheld related to net share settlement (1,151)   (1,151)    
Other comprehensive income (loss) 2,899     2,899  
Net loss (3,743)       (3,743)
Ending Balance (in shares) at Jun. 30, 2025   81,695,605      
Ending Balance at Jun. 30, 2025 $ 223,100 $ 7 $ 411,259 $ 5,968 $ (194,134)